Kööbi, Peeter <br/><br/>
AT1 receptor blockade improves vasorelaxation in experimental renal failure.  [electronic resource] 

 -  Hypertension (Dallas, Tex. : 1979)  Jun 2003 
 - 1364-71 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1524-4563 
<br/><br/><label>Standard No.: </label>10.1161/01.HYP.0000073782.30879.16  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin Receptor Antagonists<br/>Animals<br/>Aorta--chemistry<br/>Atrial Natriuretic Factor--biosynthesis<br/>Blood Pressure<br/>Endothelium, Vascular--physiology<br/>Heart Ventricles--metabolism<br/>In Vitro Techniques<br/>Losartan--therapeutic use<br/>Male<br/>Mesenteric Arteries--drug effects<br/>Natriuretic Peptide, Brain--biosynthesis<br/>Nephrectomy<br/>Peptidyl-Dipeptidase A--analysis<br/>Potassium Channel Blockers--pharmacology<br/>Potassium Channels, Calcium-Activated--antagonists & inhibitors<br/>Protein Precursors--blood<br/>RNA, Messenger--biosynthesis<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptor, Angiotensin, Type 1<br/>Renal Insufficiency--drug therapy<br/>Vasoconstriction<br/>Vasodilation--drug effects